ANALYSIS OF THE T(2-5)(P23-Q35) TRANSLOCATION BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION IN CD30(-CELL LYMPHOMAS, IN OTHER NON-HODGKINS-LYMPHOMAS OF T-CELL PHENOTYPE, AND IN HODGKINS-DISEASE() ANAPLASTIC LARGE)
A. Wellmann et al., ANALYSIS OF THE T(2-5)(P23-Q35) TRANSLOCATION BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION IN CD30(-CELL LYMPHOMAS, IN OTHER NON-HODGKINS-LYMPHOMAS OF T-CELL PHENOTYPE, AND IN HODGKINS-DISEASE() ANAPLASTIC LARGE), Blood, 86(6), 1995, pp. 2321-2328
The t(2;5)(p23;q35) translocation is associated with a high percentage
of anaplastic large-cell lymphomas (ALCL) of T- or null-cell phenotyp
e, This translocation was recently cloned and results in the fusion of
the nucleophosmin gene (NPM) on chromosome 5q35 to a novel tyrosine k
inase-encoding gene designated anaplastic lymphoma kinase (ALK) on chr
omosome 2q23. Using a sensitive and specific reverse transcription-pol
ymerase chain reaction (RT-PCR) assay to detect the NPM/ALK fusion tra
nscript, we assessed the involvement of NPM/ALK in a series of histolo
gically and immunohistochemically confirmed ALCL, in non-ALCL aggressi
ve non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disea
se (HD) to better define the morphologic spectrum of disease associate
d with this translocation. Twenty-four cases of ALCL were selected on
the basis of CD30 positivity and histologic features. Seventeen cases
presented as classical nodal and extranodal disease, four cases presen
ted as primary cutaneous disease, and three were associated with human
immunodeficiency virus (HIV) infection. As ALCL may show overlapping
histology with both HD and other aggressive non-Hodgkin's lymphomas, p
articularly of T-cell phenotype (T-NHL), we also studied 34 cases of H
D and 19 of T-NHL. NPM/ALK chimeric transcripts of identical size were
detected in 11 of the 24 (46%) cases of ALCL. NPM/ALK fusion transcri
pts were found in 11 of 17 (65%) classical ALCL cases but were not det
ected in the four primary cutaneous cases of ALCL or in the three HIV-
related ALCL cases. In addition, NPM/ALK transcripts were not detected
in any of the 34 cases of HD or in the 19 cases of T-NHL. These data
indicate that NPM/ALK fusion transcripts occur in a high percentage of
classical nodal ALCL (65%). In addition, these data strongly suggest
that ALCL, as defined in this study, is not pathogenetically related t
o either HD disease or the majority of other types of aggressive T-NHL
.